BMRA Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
987.0K
-18.4%
1.2M
-12.3%
1.4M
+84.2%
749.0K
-33.1%
1.1M
Cost of Revenue
1.0M
-11.0%
1.2M
+21.2%
956.0K
-3.7%
993.0K
-9.7%
1.1M
Gross Profit
-44000
-186.3%
51.0K
-88.0%
424.0K
+273.8%
-244000
-1384.2%
19.0K
Operating Expenses
1.3M
-11.9%
1.4M
-7.7%
1.5M
+16.8%
1.3M
+7.4%
1.2M
R&D
178.0K
-7.8%
193.0K
-9.0%
212.0K
-15.9%
252.0K
+16.1%
217.0K
SG&A
1.1M
-12.6%
1.2M
-7.4%
1.3M
+24.5%
1.1M
+5.5%
1.0M
Operating Income
-1298000
+5.5%
-1373000
-22.8%
-1118000
+28.5%
-1564000
-29.3%
-1210000
EBITDA
-1278000
+5.5%
-1353000
-23.2%
-1098000
+28.7%
-1541000
-29.6%
-1189000
Net Income
-1312000
+0.6%
-1320000
-66100.0%
2.0K
+100.1%
-1544000
-32.8%
-1163000
EPS (Basic)
$-0.44
+2.2%
$-0.45
$0.00
+100.0%
$-0.61
-27.1%
$-0.48
EPS (Diluted)
$-0.44
+2.2%
$-0.45
$0.00
+100.0%
$-0.61
-27.1%
$-0.48
Shares (Diluted)
3.0M
+3.5%
2.9M
+10.2%
2.6M
+3.6%
2.5M
+6.2%
2.4M
BIOMERICA (BMRA) โ€” Financials